With Sanex Buy, Colgate Boosts Its Personal-Care Game In Europe
This article was originally published in The Rose Sheet
Executive Summary
By acquiring Unilever's Sanex brand for roughly $940 million, New York-based Colgate-Palmolive is strengthening its presence in Europe and rounding out its global product portfolio with a premium-priced, "therapeutic" personal-care line, the firm says.
You may also be interested in...
Colgate Doubles Down On Premium Skin Care With $1.7bn Filorga Acquisition
Back in April, CEO Noel Wallace noted Colgate’s interest in further skin-care M&A during his first quarterly presentation at the firm’s helm. The Filorga purchase is significantly bigger than 2018 deals that whet Colgate’s appetite for high-growth, high-margin skin care and represents a gateway to the fast-growing travel retail channel.
Colgate Spreads Sanex Skin Care Around Europe To Spur Growth
Colgate highlights expansion plans for its Sanex skin care brand with line extensions in hand and body lotion, aspiring to capture European market share from established players including Beiersdorf, L'Oreal and J&J.
Colgate Looks To European Sanex Expansion For Growth
Colgate-Palmolive highlighted expansion plans for its Sanex skin-care brand at the Consumer Analyst Group of New York conference Feb. 19. With line extensions in hand and body lotion, the firm aspires to capture European market share from established players including Beiersdorf, L'Oreal and J&J.